EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN

PURPOSE: To evaluate the efficacy and safety of intravitreal aflibercept injection (IAI) in Japanese patients with diabetic macular edema (DME). METHODS: VIVID-DME was a Phase 3 study comprising patients with DME randomized 1:1:1 to IAI 2 mg every 4 weeks (2q4), IAI 2 mg every 4 weeks until Week 16...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Retina
Auteurs principaux: Terasaki, Hiroko, Shiraki, Kunihiko, Ohji, Masahito, Metzig, Carola, Schmelter, Thomas, Zeitz, Oliver, Sowade, Olaf, Kobayashi, Masato, Vitti, Robert, Berliner, Alyson, Shiraga, Fumio
Format: Artigo
Langue:Inglês
Publié: Retina 2019
Sujets:
Original Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6510325/
https://ncbi.nlm.nih.gov/pubmed/29470308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000002100
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires